145 related articles for article (PubMed ID: 31809857)
1. Kinetic stability of amorphous dipyridamole: A fast scanning calorimetry investigation.
Lapuk SE; Mukhametzyanov TA; Schick C; Gerasimov AV
Int J Pharm; 2020 Jan; 574():118890. PubMed ID: 31809857
[TBL] [Abstract][Full Text] [Related]
2. Crystallization kinetics and glass-forming ability of rapidly crystallizing drugs studied by Fast Scanning Calorimetry.
Lapuk SE; Mukhametzyanov TA; Schick C; Gerasimov AV
Int J Pharm; 2021 Apr; 599():120427. PubMed ID: 33662469
[TBL] [Abstract][Full Text] [Related]
3. Kinetic stability of amorphous solid dispersions with high content of the drug: A fast scanning calorimetry investigation.
Lapuk SE; Zubaidullina LS; Ziganshin MA; Mukhametzyanov TA; Schick C; Gerasimov AV
Int J Pharm; 2019 May; 562():113-123. PubMed ID: 30902705
[TBL] [Abstract][Full Text] [Related]
4. Stability of Rapidly Crystallizing Sulfonamides Glasses by Fast Scanning Calorimetry: Crystallization Kinetics and Glass-Forming Ability.
Lapuk SE; Mukhametzyanov TA; Schick C; Gerasimov AV
J Pharm Sci; 2024 May; 113(5):1257-1264. PubMed ID: 38070775
[TBL] [Abstract][Full Text] [Related]
5. An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: A case study with dipyridamole and cinnarizine.
Baghel S; Cathcart H; Redington W; O'Reilly NJ
Eur J Pharm Biopharm; 2016 Jul; 104():59-71. PubMed ID: 27108783
[TBL] [Abstract][Full Text] [Related]
6. Kinetic Stability and Glass-Forming Ability of Thermally Labile Quinolone Antibiotics.
Lapuk SE; Mukhametzyanov TA; Schick C; Gerasimov AV
Mol Pharm; 2023 Jun; 20(6):3202-3209. PubMed ID: 37133972
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
8. The Development of Quasi-isothermal Calorimetry for the Measurement of Drug-Polymer Miscibility and Crystallization Kinetics: Olanzapine-Loaded PLGA Microparticles.
Askin S; Zhao M; Gonçalves AD; Gaisford S; Craig DQM
Mol Pharm; 2018 Aug; 15(8):3332-3342. PubMed ID: 29933697
[TBL] [Abstract][Full Text] [Related]
9. Amorphous Sulfadoxine: A Physical Stability and Crystallization Kinetics Study.
Aucamp M; Milne M; Liebenberg W
AAPS PharmSciTech; 2016 Oct; 17(5):1100-9. PubMed ID: 26531745
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical stability of cimetidine amorphous forms estimated by isothermal microcalorimetry.
Otsuka M; Kato F; Matsuda Y
AAPS PharmSciTech; 2002; 3(4):E30. PubMed ID: 12916924
[TBL] [Abstract][Full Text] [Related]
11. Vitrification of two active pharmaceutical ingredients by fast scanning calorimetry: From structural relaxation to nucleation phenomena.
Monnier X; Viel Q; Schammé B; Petit S; Delbreilh L; Dupray V; Coquerel G; Dargent E
Int J Pharm; 2018 Jan; 536(1):426-433. PubMed ID: 29225097
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Amorphous Drug Stability Predictions Using Easily Calculated, Predicted, and Measured Parameters.
Nurzyńska K; Booth J; Roberts CJ; McCabe J; Dryden I; Fischer PM
Mol Pharm; 2015 Sep; 12(9):3389-98. PubMed ID: 26236939
[TBL] [Abstract][Full Text] [Related]
13. Co-amorphous formulation of dipyridamole with p-hydroxybenzoic acid: Underlying molecular mechanisms, physical stability, dissolution behavior and pharmacokinetic study.
Guo W; Dong X; Li Y; Li C; Tian Y; Gao H; Li T; Zhu H; Wang J; Yang C
Eur J Pharm Biopharm; 2023 Mar; 184():139-149. PubMed ID: 36709922
[TBL] [Abstract][Full Text] [Related]
14. Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.
Karmwar P; Boetker JP; Graeser KA; Strachan CJ; Rantanen J; Rades T
Eur J Pharm Sci; 2011 Oct; 44(3):341-50. PubMed ID: 21884789
[TBL] [Abstract][Full Text] [Related]
15. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
[TBL] [Abstract][Full Text] [Related]
16. Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol.
Schammé B; Couvrat N; Malpeli P; Delbreilh L; Dupray V; Dargent É; Coquerel G
Int J Pharm; 2015 Jul; 490(1-2):248-57. PubMed ID: 26003417
[TBL] [Abstract][Full Text] [Related]
17. Molecular Dynamics, Recrystallization Behavior, and Water Solubility of the Amorphous Anticancer Agent Bicalutamide and Its Polyvinylpyrrolidone Mixtures.
Szczurek J; Rams-Baron M; Knapik-Kowalczuk J; Antosik A; Szafraniec J; Jamróz W; Dulski M; Jachowicz R; Paluch M
Mol Pharm; 2017 Apr; 14(4):1071-1081. PubMed ID: 28231007
[TBL] [Abstract][Full Text] [Related]
18. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
Calahan JL; Zanon RL; Alvarez-Nunez F; Munson EJ
Mol Pharm; 2013 May; 10(5):1949-57. PubMed ID: 23574401
[TBL] [Abstract][Full Text] [Related]
19. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
20. Isothermal Crystallization Monitoring and Time-Temperature-Transformation of Amorphous GDC-0276: Differential Scanning Calorimetric and Rheological Measurements.
Cheng S; Chakravarty P; Nagapudi K; McKenna GB
Mol Pharm; 2021 Jan; 18(1):158-173. PubMed ID: 33259220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
